<HashMap><database>biostudies-arrayexpress</database><scores/><additional><submitter>Jurjun Velde</submitter><organism>Homo sapiens</organism><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-16601</full_dataset_link><description>Deep RNA sequencing was performed to investigate the transcriptomic effects of siRNA-mediated knockdown of SRSF7 or SMNDC1 in the triple-negative breast cancer cell line MDA-MB-231. A total of 30 million cells MDA-MB-231 cells were seeded in 6-well plates. The following day, cells were transfected with siKinasePool siRNAs targeting SRSF7, SMNDC1, or a mock control. Samples from three biological replicates were collected 72 hours after transfection. Total RNA was isolated using the RNeasy Plus Mini Kit (Qiagen). Stranded PolyA-selected libraries were prepared and sequenced on the DNBseq platform, generating 150-bp paired-end reads on a DNBSEQ-G400 sequencer (BGI Europe).</description><repository>biostudies-arrayexpress</repository><sample_protocol>Nucleic Acid Extraction - Total RNA was isolated using the RNeasy plus mini kit (Qiagen). Samples from 3 biological replicates were used. RNA quality and quantity were measured on an Agilent-4200 Bioanalyzer.</sample_protocol><sample_protocol>Library Construction - Stranded PolyA-selected libraries were prepared using the DNBseq platform.</sample_protocol><sample_protocol>Sample Collection - A total of 30 million cells MDA-MB-231 cells were seeded in 6-well plates. The following day, cells were transfected with siKinasePool siRNAs targeting SRSF7, SMNDC1, or a mock control. Samples from three biological replicates were collected 72 hours after transfection.</sample_protocol><sample_protocol>Sequencing - 100 M 150-bp paired-end reads were sequenced on a DNBSEQ-G400 sequencer by BGI Europe.</sample_protocol><figure_sub>Organization</figure_sub><figure_sub>MINSEQE Score</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>Processed Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><data_protocol>Sequence Alignment - Reads were aligned against the human GRCH38 reference genome (gencode version 45) using the STAR aligner (version 2.7.11b).</data_protocol><data_protocol>Data Transformation - Gene expression quantification was performed concurrently during mapping with the STAR --quantMode option set to GeneCounts.</data_protocol><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><instrument_platform>DNBSEQ-G400</instrument_platform><study_type>RNA-seq of coding RNA</study_type><species>Homo sapiens</species><pubmed_authors>Bob Water</pubmed_authors><pubmed_authors>Sylvia Dévédec</pubmed_authors><pubmed_authors>Jurjun Velde</pubmed_authors></additional><is_claimable>false</is_claimable><name>RNA seq of human breast cancer cell line MDAMB231 with knockdown of splicing factors SRSF7 and SMNDC1</name><description>Deep RNA sequencing was performed to investigate the transcriptomic effects of siRNA-mediated knockdown of SRSF7 or SMNDC1 in the triple-negative breast cancer cell line MDA-MB-231. A total of 30 million cells MDA-MB-231 cells were seeded in 6-well plates. The following day, cells were transfected with siKinasePool siRNAs targeting SRSF7, SMNDC1, or a mock control. Samples from three biological replicates were collected 72 hours after transfection. Total RNA was isolated using the RNeasy Plus Mini Kit (Qiagen). Stranded PolyA-selected libraries were prepared and sequenced on the DNBseq platform, generating 150-bp paired-end reads on a DNBSEQ-G400 sequencer (BGI Europe).</description><dates><release>2026-06-01T00:00:00Z</release><modification>2026-06-01T01:01:02.085Z</modification><creation>2026-01-29T11:22:13.327Z</creation></dates><accession>E-MTAB-16601</accession><cross_references><ENA>ERP188295</ENA><EFO>EFO_0002944</EFO><EFO>EFO_0004170</EFO><EFO>EFO_0004917</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0003816</EFO><EFO>EFO_0003738</EFO><EFO>EFO_0004184</EFO></cross_references></HashMap>